Synaptogenix Inc (SNPX)

[runncoach]

Interesting read. I would say I'm surprised that no one is willing to spend research money on late stage alzheimer's but it just goes to show how impossible BP thinks it is to treat...wherein lies the problem for us I think as far as having to actually PROVE we are making a difference as opposed to earlier stage companies who essentially only have to show some regression of tau or some pre-clinical slowing of anything memory related. I just don't think wall street or BP know what to think of byrostatin even with the massive amounts of research into the drug and figure what do they have to lose by waiting for us to PROVE improved cognition in an additional trial. I think someone will choose to throw in with us before we get to the data reveal, hopefully well before then but we have the money for the trial and would certainly be in the drivers seat if results turn out well.

I also wonder if the fragile X trial will come into play. If this is a smaller trial with a 15 week treatment period again, its very likely results could be released sooner than the confirmation trial and could potentially give the stock a real boost based on a potential first real treatment of that disease AND further de-risking of the MOA. Would certainly drive the stock significantly higher and would also be an additional gamble BP takes in waiting for the Alz results. JMHO